INTRODUCTION
Current United States Environmental Protection Agency (USEPA) guidance suggests that it is acceptable to consider only a ''reasonable maximum exposure" (RME) when assessing the potential human health risks associated with exposure to environmental contaminants (USEPA 1989 (USEPA . 1992a ). An RME. as defined by the USEPA. is the "highest exposure that is reasonably expected to occur" and is estimated by using upperbound values (often the upper 95th confidence limit) of the environmental contaminant concentrations and human exposure factors (USEPA, 1989) . Although perhaps useful as a screening method to determine if risks fall below a de minimis value. this approach should not be considered an accurate estimate of the potential health risks associated with a specific site or condition (Paustenbach et a /., 1990) . As noted by Burmaster and Lehr (1991 ) , rather than estimate the risks to the 95th percentile person, the RME approach can often predict the risks for the 99.9th percentile person.
The deficiencies in the RME approach were discussed at a recent symposium held at the National Academy of Science (NAS, 1992) which was sponsored by the USEPA and others. A consensus was reached by the conference attendees that the optimal method for characterizing health risks was to use probability-based techniques, such as a Monte Carlo analysis (Finley and Paustenbach, 1993) . One advantage of using this approach is that it allows consideration of a range of plausible values for contaminant concentrations. each having as many as I 00 exposure parameters, and a number of cancer potency factors; as opposed to the point estimate approach for which no quantitative information regarding uncertainty is provided (Finkel, 1990; Burmaster and Lehr. 1991: Burmaster and von Stackelberg, 1991; Paustenbach et a/., 1991 b; McKone and Bogen, !991, 1992) . As noted by those who have used the techniques, a description of uncertainty in the exposure and risk estimates will nearly always improve the quality of risk management decisions since it provides the range and relative frequency of the estimated health risks and the associated probabilities.
The advantages and disadvantages of the point estimate approach and the RMEI scenario have been addressed in a number of papers. In an attempt to remedy these, the EPA Exposure Assessment Group recently proposed using the "central" and "high end" scenario method. The central scenario "corresponds to average or median levels and high scenarios are defined as level above the 90th percentile but within the actual range of exposure levels" (USEPA, 1993) .
The Monte Carlo approach has been heralded as one of the most important advances in exposure assessment of the past 20 years. It has been used to assess PCBs in soil (Eschenroeder and Faeder, 1988) , chrome in soil (Paustenbach eta /., 1991 b) , TCE in groundwater (McKone and Bogen, 1991 ) , volatiles in ambient air (Burmaster and von Stackelberg, 1991 ) , and TCDD in soil (Paustenbach et a /., 1992a) .
In this paper, we evaluated a former wood treatment facility. Both the point estimate and probabilistic approaches were used to estimate the uptake of polychlorinated dibenzo-p-dioxins (PCDDs) and polychlorinated dibenzofurans (PCDFs) for residents living adjacent to the facility. It operated for over 60 years during which time creosote, pentachlorophenol, CCA (chromated copper arsenate), and ZMA (zinc meta-arsenate) were used· as preservatives of wooden utility poles and railroad ties. Contaminated soil and sediment were the only media of concern.
METHODS
The Monte Carlo technique has been described in several papers (Finkel, 1990: Paustenbach et a /., 1992a) . Generally, one of two or three commercial programs are used. The most popular ones are Crystal Ball ( 1991) and @Risk ( 1990) .
In contrast to the point estimate or deterministic approach, which uses single exposure values to calculate a single risk estimate (MEl, MLEI. RME, etc.) tars. pentachlorophenol. PCDDs , and PCDFs. The number of years of operation and the processing methods will usually influence the extent and severitv of contamination. Due to the environmental persistence and toxicity of the PAHs ~nd PCDDs/PCDFs. these are typically the chemicals which dictate whether remediation is necessary, and the degree of cleanup.
In an initial health risk assessment of this site, it was concluded by the A TSDR (I 988) that the health risks associated with the presence of PAHs and metals were negligible. Therefore, the authors' analysis focused on the health risks associated onlv with PCDDs and PCDFs in soils and sediment. Octachlorodibenzo-p-dioxin (OCDD) and octachlorodibenzofuran (OCDF) congeners were evaluated independently from the other PCDD and PCDF congeners. This approach was used because (I) OCDDs and OCDFs were the predominant congeners at this site, as well as at other sites where pentachlorophenol has been used; (2) the concentration times toxicity of the OCDD/ OCDF posed a potentially greater hazard than the PAHs; and (3) recent studies using rodents have suggested that the bioavailability of OCDD is significantly .)ower than that of 2,3, 7,8-TCDD (Birnbaum and Couture, 1988; Couture et a/., 1988) .
TCDD Toxicity Equivalents
Studies focusing on the structure-activity relationships of the various PCDD/PCDF congeners have clearly shown that not all PCDDs and PCDFs are equally potent carcinogens (Safe. 1987 ). This complicates many risk assessments since PCDDs and PCDFs are generally found in the environment as mixtures containing many of the possible 21 0 congeners at varying concentrations. An interim approach has been adopted by the USEPA (Bellin and Barnes, 1989) for evaluating the carcinogenic hazard posed by PCDDs and PCDFs. This approach normalizes the potency of individual congeners relative to 2,3, 7 ,8-tetrachlorodibenzo-p-dioxin (TCDD), which has a potency of 1.0. Potency values. termed toxicity equivalency factors (TEFs), have been assigned only for the 2,3,7,8-substituted congeners since numerous structure-activity and structurebinding studies have established that non-2,3,7,8-substituted congeners are relatively inactive in biological systems (Mason eta/., 1985 (Mason eta/., , 1986 Harris eta/., 1990) . The TEFs for the PCDD/PCDFs are based on their relative potencies which are estimated from the results of various biological endpoints including (I) induction of cytochrome P450-dependent monooxygenases in both human and rodent cell culture as well as in animal models, (2) immunotoxicity in mice, (3) body weight loss in a variety of animal models, (4) reproductive toxicity in mice, and (5) receptor-binding studies (Safe, 1987) . It is important to emphasize that, although the TEFs determined from these assays are used in risk assessments. the endpoints measured in these assays (e.g., increased cytochrome P450 activity) have not been shown to be directly related to the carcinogenic process or carcinogenic potency. Indeed, there is no evidence of carcinogenicity for most of the congeners assigned TEFs.
For the purposes of assessing the health risks of mixtures of PCDDs and PCDFs, the USEPA has suggested the 2,3,7,8-TCDD "toxicity equivalent" (TEQ) approach. To obtain a 2,3.7.8-TCDD TEQ value for a given congener in a mixture, the TEF value for that congener is multiplied by the concentration of the individual congener in the mixture. For example, the current international TEF (1-TEF) for OCDD is 0.00 I; therefore, ingesting 20.000 J.!g/kg of OCDD is (for regulatory purposes) theoretically as potent as ingesting 20 J.Lg/kg of 2,3,7,8-TCDD. This procedure is applied to data for each individual congener, or each class of congeners, and the 2,3, 7,8-TCDD TEQs are then summed to obtain a total 2,3,7,8-TCDD TEQ concentration in the contaminated media (Bellin and Barnes, 1989) .
The current 1-TEFs and those used previously by USEPA are presented in Table  I . The USEPA TEFs were formally adopted in the spring of 1987 and were based on data available through 1985. The 1989 1-TEFs represent modifications to the original 1987 values. For wood treatment sites, the most significant modification is the increase in TEF values for OCDD and OCDF from 0 to 0.00 I. The modification was based on the results of two studies which reported that (I) the OCDD concentration needed to achieve maximal hepatic cytochrome P450 induction was 650 times that of 2, 3, 7, OCDD is shown to accumulate in rodent tissue following repeated administration (Birnbaum and Couture, 1988) . Interestingly, approximately 75% of the PCDDs typically found in the environment are OCDD ( NRCC. 1981) and as much as 90-95% of the PCDDs at a pentachlorophenol wood treatment facility are OCDD or OCDF. Therefore, the assignment of a TEF potency value to acta-chlorinated congeners significantly increased the regulatory concern about these sites. Carcinogenicit.v 
Weight of Evidence for

in Humans
There is a good deal of epidemiological dat;;1 concerning occupational and environmental exposure to 2, 3.7,8-TCDD. Prior to 1992 . the majority of these studies reported no statistically significant increase in the overall incidence of cancers and no consistent organ-specific increased tumor rate. For example. older studies of the largest potentially exposed populations (CDC. 1987; Holm, 1986. 1987; Coggon et a/., 1986; Riihimaki eta! .. 1983; Lynge. 1985; Breslin eta/ .. 1987) and studies of production workers having presumably the highest PCDD exposures (Zack and Gaffey, 1983; Suskind and Hertzberg. 1984; Ott eta/., 1987; Bond eta/., 1983 Bond eta/., . 1988 Bond eta/., , 1989 did not demonstrate significant increases in the total incidence of cancer or a consistent organspecific excess cancer rate.
The results of the most recent epidemiological studies of dioxin-exposed populations are generally considered more informative than previous ones since better estimates of exposure are available and larger populations were studied. For example. four recent studies used blood measurements of 2.3. 7,8-TCDD to estimate past exposure (Zober eta! .. 1990; Fingerhut eta/., 1991; Manz eta/ .. 1991; Roegner eta! .. 1991 ) . Although there remains disagreement among experts about the meaning of the results, the USEPA and NIOSH believe that people exposed to very high doses are at increased risk of several diseases, including an increase in the overall cancer rate.
Two of these studies involving relatively large (> 250 cancer deaths) exposed populations (Saracci eta/ .. 1991 : Fingerhut el a/., 1991 examined the relationship between 2,3, 7,8-TCDD exposure and cancer. Saracci el a/. ( 1991) analyzed the largest cohort of production workers potentially exposed to PCDDs and reported no significant excess in overall cancers or common cancer types. However, Fingerhut ( 1992) believes that the NIOSH study, Zober el a/. ( 1990) , and Manz el a/. ( 1991) found significant excesses in the total cancer rate. The increases in the lung cancer incidence could not be fully evaluated since data about the workers smoking habits were not robust. Although no chemical or agent, heretofore. has been shown to produce an increased incidence in all cancers, some believe that a promoter such as 2,3, 7,8-TCDD could increase the risk in several organs. These data suggest that 2,3,7,8-TCDD may be able to cause a slight increased cancer risk in those who had peak body burdens above 5000 ppm. Sweeney et a/. ( 1992) reported an increased incidence of diabetes in the workers.
lmmunotoxicity
It has been suggested that the most sensitive indicator of the adverse effects associated with exposure to 2,3, 7,8-TCDD is immunotoxicity. A spectrum ofimmunotoxicological effects has been reported in animals including atrophy of thymus and spleen (associated with a reduction in the generation of cytolytic T-Iymphocytes), suppression of antibody response, effects on serum immunoglobulins, alterations in lymphocyte development and homing, reduced activity of activated polymorphonuclear neutrophils, and effects on host resistance (Holsapple ei a/., 1991 ) . Unfortunately, the available data are inadequate to quantitatively evaluate the dose-response relationship for immunotoxic effects in animals.
While the most sensitive animal responses are the acquired immune responses to primary antigen challenge. most human studies have measured either the response to various mitogens, the secondary response to recall antigens, or changes in lymphocyte subpopulations (Holsapple et a!.. 1991 in animals to humans. In an epidemiological study of 18 British workers exposed to 2.4.5-T. it was reported that the levels of BandT cells were unaltered: however, the levels of circulating natural killer (NK) cells were elevated (Jennings eta ! .. 1988) . In a study of children exposed to relatively high concentrations of 2.3.7.8-TCDD in Seveso. Italy, no changes in immune function were reported 3 years after exposure; however. 6 years postexposure an increase in complement protein levels was reported in children having overt signs of chloracne (Tognoni and Bonaccorsi. 1982) . In a study of individuals exposed in Times Beach. Missouri. a nonstatistically significant decrease in T4+ /T8+ ratios was reported: however. there was a statistically significant increase in the total number of platelets (Knutson, 1984) . The results were not reproducible in a follow-up study and no adverse effects of any type were observed (Stehr-Green et a! .. 1986 ). Due to the lack of clinical evidence of less than optimal immune function and questions about the administration of the sensitized in the original study. the _. initial findings have generally been considered an artifact.
Until recently, doses of2,3,7.8-TCDD which were low enough to produce no adverse effect on the immune system were based on studies of only guinea pigs or mice. Vos eta!. ( 1973) reported depressed delayed-type hypersensitivity (DTH) responses to tuberculin in adult guinea pigs fed a diet of 0.04 J.Lg/kg-week (6000 pg/kg-day) for 8 weeks. In an attempt to identify a regulatory limit which would prevent adverse effects on the immune system of humans. the United Kingdom applied a safety factor of 100 to this minimal effect level and they suggested a 60 pg/kg-day exposure guideline (UK, 1989).
Developmental and Reproductive Toxicity
The developmental toxicity of2.3.7.8-TCDD has been evaluated on several occasions in animals. Teratogenic effects have been reported in mice at doses less than those resulting in maternal toxicity: however, developmental effects in other species have been noted only at maternally toxic doses (ATSDR, 1988; Couture et a! .. 1990 ). In contrast, hydronephrotic kidney and cleft palate have been reported at doses as low as I J.Lg/kg in C57BL/6N mice (Couture eta!., 1990) .
Birnbaum et a!. (I 987) treated pregnant mice with either 2,3,4, 7 ,8-PeCDF (0-30 J.Lg/kg) or 1,2.3,4,7,8-HxCDF (0-300 J.Lg/kg) on Gestation Days 10-13, followed by necropsy on Day 18. Both chemicals were found to cause hydronephrosis and cleft palate in the fetuses without overt toxicity to the dam (Birnbaum eta!., 1987) . Weber eta!. (1984) reported teratogenic effects of2,3,7.8-TCDF in C57BL/6N mice at doses of 250 J.Lg/kg. Schwetz et a!. ( 1973) investigated the effect of OCDD on the maternal and fetal body measurements as well as the incidence of fetal resorption in rats. At doses as high as 500 mg/kg-day. no significant difference from control groups was observed with regard to fetal body measurements, maternal weight gain. or fetal resorption.
Developmental effects have been reported in the rabbit at doses associated with chemically induced maternal stress (Khera, 1984 (Khera, , 1987 . There is no evidence that PCDDs or PCDFs, including 2.3. 7.8-TCDD, act as developmental toxicants in humans (ATSDR. 1988 : Couture eta! .. 1990 .
Reproductive effects associated with administration of 2,3. 7.8-TCDD have been 'J reported in rats. mice. rabbits. and nonhuman primates (DHS. 1985: A TSDR. 1988 ) .. · In a three-generation study of Sprague-Dawley rats fed a diet containing doses of O, 0.00 I. 0.0 I. and 0.1 j!g/kg-day for 90 days, a significant reduction in fertility and litter size was observed in the f 0 offspring of female rats receiving 0.1 j!g/kg-day. At 0.01 j!g/kg-day, significant reductions in fertility, postnatal survival, and growth were observed in f 1 and f 2 generations. Significant decreases in gestational survival, litter size, and average postnatal body weight were noted among the f 2 and f 3 litters of this same dose group. The authors concluded that 0.00 I j!g/kg-day was a no-observable-effect level (NOEL). NOELs for reproductive toxicity in nonhuman primates are lower than those reported for rodents. In a subchronic fetotoxicity study, McNulty ( 1984) reported occurrences of abortion in rhesus monkeys treated with I jig/kg of 2,3, 7,8-TCDD between Days 20 and 40 of gestation. At 0.2 j!g/kg, I of 4 animals aborted. A low incidence of palatal abnormalities was the only developmental effect reported. The authors concluded that the number of animals in the 0.2 j!g/kg group was not adequate for statistical evaluation or the assignment of a NOEL.
Ther:e.is insufficient evidence to indicate that 2,3,7,8-TCDD is a reproductive toxicant in humans. Epidemiological studies have been conducted for human populations exposed to 2,3, 7,8-TCDD in herbicides and other industrial chemicals, and no adverse effects have been reported for reproductive performance in exposed males, or developmental effects in offspring (A TSDR. 1988 ). Because of the limitations in these studies, particularly in terms of exposure, the results of the Ranch Hand investigation of Army personnel working with Agent Orange, likely to be completed in 1993, are of special interest.
SITE-SPECIFIC DATA
Soil and Sediment Data
At this site, a total of 23 off-site surface soil and sediment samples were collected and these were used to estimate exposure to residents (Table 2) . Thirteen samples were collected by the USEPA in locations approximately 500 to 3000 feet from the site and 10 additional off-site samples were collected by an independent contractor. Six surface soil samples were collected near the residences adjacent to the facility. Seventeen sediment samples were collected from nearby drainage ditches which may or may not ha'-:e historically received runoff from the site (Fig. I) .
The soil and sediment samples were analyzed for pentachlorophenol (USEPA Method 8040) and 2,3,7,8-substituted PCDDs and PCDFs (USEPA Method 8280). Pentachlorophenol was not detected in any sample at a limit of detection of I. 7 mg/ kg. Soils were also analyzed for metals and polycyclic aromatic hydrocarbons (PAHs); however, the frequency of detection and concentrations were not considered to be significant and were therefore not quantitatively assessed.
Six types of data were considered in our analysis: octa congeners, non-octa congeners, and all congeners combined. A Kolmogorov-Smirnov distribution analysis (Wilkinson, 1989) was conducted on each of the data sets to determine the appropriate distribution. The results indicated that the soil and sediment contaminan.t concentrations were neither normally nor lognormally distributed ( Fig. 2) , in part, due to the small sample size. The octa congener data for the six soil samples taken in the residential area appeared to (and would be expected to) fit a lognormal distribution.
., 
The concentrations of PCDDs and PCDFs (reported as 2.3.7.8-TCDD TEQ) are presented in Table 2 . . Most of the congeners were not detectable in a majority of the samples. In the exposure calculations. one-half the detection limit was used whenever no detectable quantity was measured. as recommended by various guidance documents (USEPA, 1989) and several published papers (Parkin et a Haas and Scheff, 1990; Travis eta/., 1990) . As shown in Table 2 Nore. Soil: soil samples collected near residences (see Fig. I for sample location). Sed: sediment samples collected from drainage ditches (see Fig. I for sample location).
• Reponed as 2.3.7.8-TCDD TEQ.
b Sum of mono-through hepta-substituted congeners. ,. Octa-substituted congeners only.
Air-Sampling Data
Sampling for airborne particulates was conducted during the remediation of onsite soils. The data were used to estimate the airborne concentration ofPCDD/PCDFs in residential areas. Five air-monitoring stations located on-site (n = 3) as well as in adjacent residential areas (n = 2) collected particulate samples on three consecutive days (Table 3) .
DOSE-RESPONSE ASSESSMENT
2,3, 7,8-TCDD has not been shown to be an initiator (Shu et a/., 1987) ; however, it may act as a promoter of carcinogenic processes. Promoters require a minimum threshold dose to elicit the necessary cellular responses leading to tumor growth (Wassom, 1977; Shu et a/., 1987; Hebert et a/., 1990 
Results of Kolmogorov-Smimov data distribution analysis (Wilkinson, 1989) for soil and sediment data. This analysis determines the shape and location of a sample distribution based on the maximum difference between a continuous :md a discrete cumulative distribution function. The graphs are generated as cumulative probability plots for each data set. Only one data set (soil data for the octacongeners) appeared to fit a lognormal distribution: however. the number of samples was not adequate to define the distribution.
have previously used a threshold approach for evaluating 2,3, 7,8-TCDD cancer risks, i.e., establishing a no-observable-adverse-effect level (NOAEL) for estimating "safe" or acceptable levels of exposure (Fries and Paustenbach, 1990) . For 2.3, 7,8-TCDD, a NOAEL of I ng/kg-day in rats has been reported in both a three-generation reproduction study (Murray eta/., 1979) and a 2-year carcinogenicity study (Kociba eta/., 1978) . On the basis of these studies. some regulatory agencies in Canada. The Netherlands, Germany, and the United States l1ave developed threshold-based exposure guidelines of 1-10 pg/kg-day by applying safety factors ranging from I 00 to 1000 to the NOAEL (Paustenbach eta/.. 1992b).
In assigning a cancer potency factor (CPF) for 2,3, 7,8-TCDD, some federal agencies such as the USEPA have relied on the use of nonthreshold dose-response models to develop a cancer potency value based on the Kociba et al. ( 1978) bioassay data. The use of these models is based on the assumption that there is no threshold for carcinogenesis. _i.e., any dose poses some level of risk (Krewski eta/., 1989) . Cancer potency estimates for 2,3.7,8-TCDD have been calculated by the USEPA (1985a). the CDC (Kimbrough et al .. 1984) , the FDA ( 1983), and selected states. The differences in estimated potency are dependent on how one interprets the rodent bioassay data. the Table 4 are based on the bioassay data generated by Kociba et a/. ( 1978) or a combination of those data and the results of the study conducted by the NTP using mice (Kimbrough eta/., 1984) . The cancer potency factor (CPF) assigned by the VSEPA in 1989 for 2,3, 7,8-TCDD is 1.56 X 10 5 (mg/kg-day)-
1
• The CPF for 2,3,7,8-TCDD has recently been recalculated using the results of the histopathological reevaluation of the Kociba eta/. study (Keenan et a/., 1991 ) . Using survival-adjusted tumor incidence data, the LMS model, and scaling up to humans using body weight rather than surface area, the CPF for 2,3,7,8-TCDD is 2700 (mg/kg-day)-1 based on the incidence of hepatocellular carcinomas I X 10-6 I X 10-5 I X 10-6 I X 10-5 I X 10-6 I X J0-5 I X 10-6 I X 10-5 I X 10-6 I X 10-s 1 when hepatocellular carcinomas and adenomas were combined. When the data were not adjusted for survival rates, the estimates ranged from 1500 to 8.200 (mg/kg-dayt 1 • These ranges are approximately 16-to 58-fold Jess than the USEPA 's CPF of 156,000 (mg/kg-day)-1 and equate to an acceptable daily intake (at a I X 10-6 risk level) of 100 to 370 fg/kg-day. We developed a probability distribution for the CPF of2,3, 7,8-TCDD using a version of the LMS model which provides the necessary data as a subprogram (Crouch, 1992) . The probability distribution is shown in Fig. 3 . The 95th percentile value of 9700 (mg/kg-day)-1 was used in point estimate (deterministic) approach.
EXPOSURE ASSESSMENT
In this assessment, the authors focused solely on the possible risks associated with residential exposure to soil or sediment. Residents were assumed to have no direct access to the former site since it is fenced. However, because samples from drainage ditches leading away from the site contained higher concentrations of PCDDs and PCDFs than those of soil samples collected in residential areas, a recreational scenario in which children played in the drainage ditch 5 hr per week was evaluated. The recreational scenario was considered extremely conservative due to the fact that one ditch is isolated by fencing, both ditches are currently undergoing remediation, and because children would not be expected to play in the ditch frequently.
The uptake of PCDD/PCDF due to soil ingestion and dermal contact by children 1.5 to 12 years old was estimated by summing the estimated uptake due to residential exposure (97% of the lifetime) with uptake due to the recreational exposure (3% of the lifetime). The estimate of uptake by residents was based on the results of soil sampling from residential yards and recreational exposure was based on the results of sediment sampling (Table 2) . For adults, uptake due to soil ingestion and dermal contact was estimated based on the concentrations found in residential soil because it was assumed that adults did not have routine contact with the soil in the drainage . (Crouch. 1992 ) and histopathological reevaluation of cancer bioassay data (Keenan et a/.. 1991) . Snyder. 1975 • USEPA. 1990 Site-specific USEPA. 1985b • Reference for point estimate value(s), if different from reference for distribution value. N/ A, not applicable. (The equation provided by Hawley ( 1985) was not used in the point estimate to calculate surface area.) ditches. Uptake due to the inhalation of particulate pathways and ingestion of inhaled particulates was calculated for all age groups using residential exposure assumptions and air sampling data. Exposure due to the ingestion of mother's milk by nursing children was estimated for the 0-to 1-year age group.
In the Monte Carlo analysis, the simulations began at the time of the sampling, which is assumed to be the time of birth for the resident. The exposure factors used to estimate the lifetime average daily dose (LADD), for both the deterministic and probabilistic assessments, are presented in Tables 5-10 .
Soil Ingestion
The incidental ingestion of soil by both adults and children was considered to be predominantly due to incidental hand-to-mouth contact as a result of activities such as gardening and normal outdoor play. The lifetime uptake due to ingestion of soil is a function of the chemical concentration in surface soil, the oral bioavailability of the contaminant in the soil matrix, the half-life of the contaminant in soil, the age-specific soil ingestion rate, and the frequency of contact with soil (USEPA, 1989; Paustenbach et a/., 1991 Paustenbach et a/., b, 1992a 
PCDD/PCDF Concentralions in Surface Soil
The PCDD and PCDF concentrations in soil and sediment are presented in Table  2 (Geraghty & Miller, I990a; USEPA, 1991 b) . For the deterministic assessment, the concentration at the beginning of the exposure period was assumed to be represented by the 95th upper confidence limit (UCL) of the arithmetic mean of the soil (or sediment) data. Representative lifetime concentrations were estimated by assuming a chemical half-life in soil of 35 years, age-specific exposure periods, and first order degradation/loss kinetics .
For the probabilistic analysis, the individual soil or sediment sample results were considered as discrete data points (each had an equal probability of representing the exposure concentration) due to the relatively small sample size. This approach is consistent with that recommended by McKone and Bogen ( 1991 ) . Ranges for environmental half-life were considered hr the probabilistic assessment.
Oral Bioavai/ability
It has been suggested that the oral bioavailability of 2,3, 7,8-TCDD is dependent upon the dose (Lucier el a/ .. 1986) , as well as, soil-specific characteristics such as the organic content (Umbreit el a Shu eta/., 1988a) . The results of numerous studies indicate that the oral bioavailability of2,3,7,8~TCDD in animals ranges from 0.5 to 50% depending on these and other factors (Lucier eta/., 1986 ; Umbreit el a/., !986; Shu eta/.. 1988a; Birnbaum and Couture, 1988) . In the deterministic assessment, a mean value of 43% was used to characterize the oral bioavailability ofnon-octa and octa-PCDDs and PCDFs (USEPA, 1993). For the probabilistic assessment, the range reported by Shu eta/. ( I988a) of 39 to 49% was used to describe the oral bioavailability ofnon-octa congeners. A uniform distribution was assigned since there were inadequate data to accurately assign a distribution.
Little information exists on the oral bioavailability of PCDDs and PCDFs other than 2,3,7,8-TCDD; however, results of a study conducted by Couture et a/. (1988) suggest that the oral bioavailability ofOCDD is less than that of2.3,7.8-TCDD. Specifically, 1.5 to I 0% of the OCDD dose was absorbed when rats were orally administered 500 or 5000 mg/kg OCDD in corn oil, whereas about 80% of 2,3, 7.8-TCDD in corn oil was absorbed. By analogy to the data for 2.3,7,8-TCDD, we assumed that soilbound OCDD was approximately 10-fold less bioavailable than 2.3.7.8-TCDD in soil. Since most assessments have used values of 25-50% for the oral bioavailability of 2.3,7 ,8-TCDD in soil, we chose a uniform distribution of 2.5 to 5% to represent the oral bioavailability of OCDD/OCDF in soil in humans.
Environmental DegradaLion of PCDDs and PCDFs in Soil
Because the source of contamination is no longer present at this site. soil concentrations throughout the total exposure period were corrected to account for the known degradation/loss of PCDD/PCDFs in surface soil over time. Degradation generally follows an exponential decay process described by the following equation:
This equation provides an estimate ofthe amount of chemical (N) remaining at time T given the initial concentration at time N 0 , and the first order decay constant, k. To calculate the average concentration C.v over the interval time T 1 to T 2 , the concentration must be summed over the time period of interest and divided by the total time, T 2 -T 1 • Subsequent to integrating equation (I) and substituting C for N from T 2 -T 1 , the following equation was used to estimate a representative chemical concentration for any time interval of interest:
(2) Although a range of values has been reported for the environmental half-life of 2,3,7,8-TCDD in soil, it is clear that 2,3,7,8-TCDD is very stable. Variability in soil half-life has been attributed tQ differences in soil type, climatic factors, the depth of soil contamination, and the presence of cocontaminants (Cerlesi eta/., 1989; Yanders eta! .. 1989 Yanders eta! .. , 1990 Paustenbach eta! .. 1991 a) . The factors contributing to loss include photodegradation, volatilization, and leaching and surface runoff (Podoll eta/., 1986; Freeman and Schroy, 1989: Arthur and Frea, 1989; Yanders eta/., 1989 Yanders eta/., , 1990 . There is no good evidence for biologic degradation of 2,3, 7,8-TCDD in soil. These factors have been considered by investigators who generally agree on a range of 9-35 years for the half-life of2,3;7,8-TCDD in surface soils 0 to 3 inches) (di Domenico, 1990; Gough, 1991 ; Paustenbach et a/., J992a). A half-life of 30-100 years is plausible for subsurface 2,3, 7,8-TCDD (Pa·ustenbach et a/., 1992a). Due to a paucity of environmental half-life data on congeners other than 2,3, 7,8-TCDD, a uniform distribution of 9 to 35 years was used in the probabilistic assessment for all congeners. A half-life of 35 years was used for all congeners in 'the deterministic assessment.
Soil Ingestion Rate
Numerous investigators have attempted to estimate the soil ingestion rates for both children and adults (Kimbrough eta/., 1984; Hawley, 1985; Paustenbach, 1987; Davis et a/., 1990; Calabrese et a/., 1989 Calabrese et a/., , 1990 Van Wijnen et a/., 1990; USEPA, 1990; Paustenbach et a/., 1992a; Calabrese and Stanek, 1992) . The more sophisticated studies use tracer elements to estimate soil ingestion rates. The results of the most thorough and most accurate investigation suggest that soil ingestion rates range from 9 to 40 mg/day for young children (Calabrese et a/., 1990) . Later work by the same group, which used zirconium as a tracer, confirmed this range and concluded that the data were lognormally distributed with a geometric mean of 20.5 mg/day and a standard deviation of 87 mg/day (Calabrese and Stanek, J99la, b) . Accordingly, this range of values was used to characterize soil ingestion for ages 1.5 to 12 years. Estimates of soil ingestion rates for older children and adults range from I to I 0 mg/day (Paustenbach et a /., 1992a; 1992b) and these were used as the soil ingestion rates for the 12-to 70-year age group. Consistent with the approach used in other assessments (Paustenbach eta!.. 1991 b), a uniform distribution was assigned to this age group. The soil ingestion rates of 200 and 50 mg/day estimated by the USEPA ( 1992b) for children and adults, respectively, were used in the deterministic assessment. Exposure Fn'tfl/<!11(1' For the ingestion of soil it was assumed that children were exposed to contaminated sediment from the drainage ditch for 5 hr per week (3% of the total exposure period) and were exposed to soils in the residential area for 97% of the exposure duration.
Exposure Duration
The USEPA has estimated ranges for residence time based on data collected by the Bureau of the Census (USEPA, 1985a). Ranges for residential tenure were based on the number of years each person in the survey lived in their current household. For the probabilistic assessment. these ranges were normalized for age group and each range was assumed to have a uniform distribution. The deterministic assessment used standard regulatory-suggested default values (Table 5) for exposure duration (USEPA, 1989).
Body Weight
The range of body weights in the population is know to be normally distributed (Snyder, 197 5) . Percentile distributions for body weight for men and women, and male and female children, were developed by the USEPA ( 1985a) using data obtained in the National Health and Nutrition Examination Survey (NHANES) II. The agespecific body weight ranges presented in the study were used in the probabilistic assessment. The mean body weight for each age group was used in the deterministic assessment.
Estimation of Uptake Due to Ingestion of Soil
The equation used to estimate PCDD/PCDF uptake due to incidental ingestion of soil was LADD = (C 50 ;1 X IR X B X EF X ED}/(BW X AT). The values used to estimate soil ingestion are presented in Table 6 . The probability distribution for uptake via soil ingestion is presented in Fig. 4 . The 50th and 95th percentih!"LADDs for soil ingestion are 6.6 X 10-14 and 7.6 X 10-13 mg/kg-day (TEQ). respectively. The estimate for uptake via soil ingestion was 3.6 X 10-10 mg/kg-day using the point estimate approach, which is 473-fold greater than the 95th percentile dose predicted by the probabilistic assessment. Octa congeners contributed 6% (50th percentile) and 10% (95th percentile) to the total soil ingestion dose.
Uptake of Inhaled Particulates
To estimate the uptake of PCDD/PCDFs via inhalation, the following parameters must be accounted for: the contaminant concentration in air (as particulate), inhalation rate, fraction of inspired particles retained in lung, and particulate bioavailability in the lung.
Contaminant Concentration in Air
Average values for three consecutive days of sampling, at the five air monitoring stations, were used to estimate the airborne concentrations of PCDD/PCDF (Table  3) . For the 180-day period of site remediation, the average concentrations of airborne particulates at each monitoring station were within local background ranges and therefore were not attributed to dispersion of site soils. The concentrations ofPCDD/PCDF in particulates were considered representative for both the residential and recreational scenarios and were given equal probability (e.g., treated as discrete values) in the probabilistic analysis. The highest of the five values was used in the deterministic assessment.
Respirable Particle Fraction
The deposition of inhaled particulates in the lung is dependent on the particle size. Because site-specific data on particle size distribution were not available, the mass mean aerodynamic diameter (MMAD) was conservatively assumed to be 2.4 J.Lm. This is regarded as a conservative assumption as generally 70% of airborne particulates (by weight) are larger than 2.4 J.Lm in diameter (Trijonis et a/., 1980) . The ICRP ( 1966) derived a model relating the particulate size distribution and breathing rates to the deposition pattern. Based on results from this model, a value of 20% of inspired particulates was assumed to be available for pulmonary absorption (ICRP, 1966 ). An upperbound value of 33% was used in the deterministic assessment.
Inhalation Rate
Total ventilation or minute volume, VE (liters/min), has been correlated with the three-fourths power of body weight (kg) for purposes of pharmacokinetics modeling (USEPA, I 988). For humans, the relationship is
This equation was applied to the age-specific body weight distributions described above to characterize age-specific ventilation rates in the probabilistic assessment. For the ··deterministic assessment, standard inhalation rates were used (Snyder, I 975) . The values for the probabilistic and deterministic assessments are presented in Table 7 . 
Exposure Frequency
It was assumed that both children and adults were exposed to airborne dust for 365 days per year (fraction of year exposed = I). This is an unreasonably conservative approach since most eastern and southeastern states have about 200 days per year of either frozen soil or precipitation. which effectively eliminates dust resuspension from soil.
The values for exposure frequency, exposure duration. and body weight used to calculate the dose via soil ingestion were also used to estimate uptake via inhalation.
Estimating Uplake via Inhalation
The equation used to estimate uptake via inhalation of particulates was: The values used to estimate uptake via inhalation are presented in Table 7 . The probability distribution for the uptake via inhalation is presented in Fig. 4 . The 50th and 95th percentile LADDs are 3.8 X 10-13 and 1.1 X 10-12 mg/kg-day, respectively. The ·~ acta congeners represented 25% of the total dose at the 50th and 95th percentiles. The uptake of PCDD/PCDF using the deterministic approach was 1.3 X I o-11 mg/kg-day (TEQ). about 13-fold greater than the 95th percentile dose.
Ingestion of Inhaled Particulates
The fraction of respirable particles that is swallowed should be considered when assessing total uptake of PCDDs/PCDFs (Leung et a/., 1990; Sheehan et a/ .. 1991 ) .
The dose due to ingestion of inhaled particulates results from the deposition of inhaled particulates in·· upper regions of the respiratory tract. Approximately one-half of the 8% of particulates deposited into the tracheobronchial region are rapidly cleared by ciliary mucous transport. leaving 4% available for systemic absorption via ingestion (Paustenbach et a! .. 1986; Sheehan et a! .. 1991 ) . Furthermore, approximately 42 to 6 7% of inhaled particulates are deposited in the nasopharynx and consequently swallowed. Thus, on the average, 58% of inhaled particulate matter reaches the gastrointestinal tract (ICRP. 1966) . Accordingly, this value was useo in the probabilistic assessment. An upperbound value of 67% was used in the deterministic assessment.
The dose from ingestion of inhaled particulates was calculated using the equation (6) PDF data and point estimate values are presented in Table 8 . The probability distribution for dose via ingestion of inhaled particles is presented in Fig. 4 . The 50th and 95th percentile LADDs due to ingestion of large airborne particles are 3.3 X 10-13 and 1.3_ X 10-12 mg/kg/day (TEQ}, respectively. Octa congeners represented 3% of the total dose at both the 50th and 95th percentiles. The LADD predicted by the deterministic assessment was 1.3 X 10-11 mg/kg-day, approximately 9-fold greater than the estimated 95th percentile dose.
Dermal Uptake
Factors influencing the amount of soil-bound chemical that may be dermally absorbed include chemical concentration in surface soil, skin surface area available for contact, skin adherence properties of soil, and dermal bioavailability (USEPA, 1992b; Paustenbach and Leung, 1992) .
Chemical Concentration in Surface Soil
The chemical concentrations in soil are discussed in the section on soil ingestion and are presented in Table 2 .
Skin Surface Area
Age-specific ranges for exposed skin surface area were developed based on the relationship of body surface area to height and weight (Hawley, 1985) : 
., Age-specific ranges for exposed body surface area in the probabilistic assessment were based on Eq. (4} (Hawley, 1985) . In developing the distributions for exposed body
,.
,. surface area. body weight was described by a normal distribution and height was described by a uniform distribution (USEPA. 1985a). For the deterministic assessment, values recommended by USEPA ( 199Ia, I992a) were used (Table 9) .
Skin Adherence Factor
Several studies suggest that the amount of soil which can adhere to the skin is between 0.2 and 1.0 mg/cm 2 (Lepow eta Roels eta/., 1980; Que Hee et a/ .. 1985; Driver et a/., 1989: Paustenbach and Leung, 1992) . The range of 0.2 and 1.0 mg/cm 1 • suggested by USEPA (1992b), was used to estimate the degree of soil adherence. This factor was assumed to have a uniform distribution (Paustenbach et a/ .. ~· 1991c). The upperbound value of I mg/cm 2 value suggested by the USEPA (1992b) was used in the deterministic assessment.
Dermal Bioavailability
A range ofO.I to 2% for the dermal bioavailability of PCDD/PCDF in soil was used in the probabilistic assessment. based on data from rat studies (Poiger and Schlatter, 1980; Shu et a/., 1988b) and information regarding the relative permeabilities of rat and human skin (Bartek eta /., 1972: Bartek and La Budde, 1975; Shu eta/ .. 1988b; Banks and Birnbaum, 1991 ) . Because data regarding the distribution frequency for this parameter were not available, a unifurm distribution was used in the Monte Carlo analysis. The upperbound value of 2% was used in the deterministic assessment.
Recently. a fugacity model was offered to estimate the dermal uptake of organic chemical contaminants from a soil matrix (McKone, 1990) . The model considers a number of factors not considered previously in estimating dermal uptake of a chemical from a soil matrix. These factors include the mass transfer of chemical from soil to air, soil to skin, and skin to systemic circulation. McKone tested the model by predicting an uptake of soil-bound 2,3, 7.8-TCDD from rat skin, using the laboratory conditions of experiments conducted by Poiger and Schlatter ( 1980) and Shu eta/. ( 1988b) . The results of McKone's model predicted an uptake of 0.5%. which is comparable to the value of I% suggested in the two laboratory studies.
Estimating Dermal Uptake
The values for exposure duration. exposure frequency, body weight. and averaging time used to estimate uptake via soil ingestion ( USEPA. 1985a USEPA. . 1990a ) were used to estimate dermal uptake. The equation used to estimate dermal uptake was LADD = (C 50 ; 1 X SAF X SA X B X EF X ED)/(BW X AT),
where LADD = Lifetime average daily dose (mg/kg-day) C 50 ; 1 = Concentration of PCDD/PCDFs in soil (mg/kg) SAF = Skin adherence factor (kg/cm 2 /day) SA = Surface area exposed (cm 2 ) B = Bioavailability due to soil matrix binding (fraction) Miller. 1990a ; USEPA. 1990a Calabrese and Stanek. 1991a .b Paustenbach 1991 b. 1992a Calabrese and Stanek. 1991a.b Shu et a /., 1988a Birnbaum and Couture. 1988 Gough. 1991 ; di Domenico. 1990 ; Paustenbach et al .. 1991a.b Site-specific The parameter values used in both assessments to estimate dermal uptake are presented in Table 9 . The probability distribution for the LADD via dermal uptake is presented in Fig. 4 . The 50th and 95th percentile LADDs are 1.4 X 10-12 and 1.6 X 10-11 mg/ kg-day (TEQ), respectively. Octa congeners represented 49 and 60% of the risk, at the 50th and 95th percentiles, respectively. The deterministic assessment predicted a LADD of3.2 X 10-10 mg/kg-day, a value approximately 20-fold greater than the 95th percentile dose. 
Ingestion ofj\Jother's Milk
Reference Geraghty & Miller. 1990b Snyder. 1975 " USEPA. 1988 ICRP. 1966 Trijonis et al .. 1980 .. " ATSDR. 1988 Site-specific
Environmentally persistent lipophilic chemicals such as PCDDs and PCDFs are often detectable in mother's milk. Fuerst et a/. (1986) identified PCDDs and PCDFs in milk from European nursing mothers. Only 2,3,7,8-substituted congeners were detected in the milk which is consistent with data obtained when other tissue compartments were analyzed (Rappe ec a/ .. 1983; Ryan eta/., 1985 : Schecter eta/., 1985 .
OCDD (143 ppt in fat) and 1,2.3,4.6.7.8-HpCDD (49 ppt in fat) were the predominant congeners detected in the study by Fuerst eta/. ( 1986) . Chemical uptake via ingestion of mother's milk is dependent upon the mother's average daily dose, whole body halflife of the chemical, milk ingestion rate, and exposure duration.
.Hother's Average Daily Dose
The probability distribution for the mother's average daily dose developed from the Monte Carlo simulation was based on the sum of the doses estimated for all other exposure pathways. 
JVhole Bod,r Ha(f~L((e
The half-life in the human body of 2,3,7,8-TCDD has been extensively studied. Poiger and Schlatter ( 1986) investigated the pharmacokinetics of radiolabeled 2,3,7 ,8-TCDD ingested by a 92-kg male. The estimated half-life of 2.3,7,8-TCDD, for this individual, assuming first-order kinetics, was 5.8 years. Pirkle eta/. ( 1989) estimated the half-life of 2. 3.7, in the human body based on serum data from 36 Air Force Vietnam veterans exposed to the herbicide Agent Orange during spraying operations. First-order kinetics and serum concentrations for 1982 and 1987 were used to estimate the half-life for each veteran. A frequency plot of the results is shown in Fig. 5 . The median half-life for this population was found to be 7.1 years (95% confidence interval about the median of 5.8 to 9.6 years). A later study of the same population found a marginally significant dependence of half-life on percentage body fat (Michalek eta/., 1992) ; however, the specific mathematical correlation has not yet been characterized.
Because the Pirkle eta/. ( 1989) half-life estimates are based on the largest chronically ·exposed population and have been used by other investigators (Mocarelli eta/., 1991; Michalek et a! .. 1992) . their results were used in our probabilistic assessment. The data were entered as a continuous distribution with probabilities equal to the frequencies presented in Fig. 4 . We assumed that the biologic half-lives (and the distributions) for all PCDDs and PCDFs are adequately represented by the values determined for 2.3.7.8-TCDD. A value of7.1 years was used as the point estimate. Recent data suggest that the half-life in humans is closer to 12 years (Michalek eta/., 1992) . This could easily be incorporated in our analysis but would not appreciably alter our results.
Mother's iHi/k Ingestion Rate
An infant breast milk ingestion rate of 600 to 900 gm/day (Butte et a/ .. 1984 (Butte et a/ .. . 1991 has been accepted for use in risk assessment (CAPCOA, 1992) . This range is in agreement with observations by others (Lonnerdal eta! .. 1976: Whitehead and Paul. 1981 ) . RecentlS', Dewey et a/. ( 1991) reported breast milk intake rates that are correlated with infant body weight. An analysis of these data indicates that the total grams of ., 1984, 1991 4 (point estimate used)
Butte et a /., 1984, 1991 9 (point estimate used) Smith, 1987 Discrete, see Fig. 5 Pirkle La Leche, 1991 6.5 (point estimate USEPA, 1990 • Reference for point estimate value(s), if different from reference for distribution value.
b Specific relationships taken from the DARLING study (Dewey eta/., 1991 ). breast milk ingested per kilogram body weight per day are significantly different at 3, 6, 9, and 12 months of age. Accordingly, we divided the breast-feeding period of 1 year into four age-specific dose groups, for which we utilized the age-specific relationship between body weight and milk ingestion rate. The national percentage of breast-fed infants ranges from 21 to 25% (MacGowan et a/., 1991; Maxwell and Burmaster, 1992) . Consistent with Maxwell and Burmaster ( 1993) , we used a value of 22% in the analysis. For the deterministic assessment, a daily ingestion rate of 900 gfday was used.
Exposure Duration (Infant)
The length ~ftime that infants breast-feed varies significantly from family to family.
Although breast-feeding periods range from zero to well over 1 year, the most common total time period is estimated from .6 months to 1 year (La Leche, 1991 ) . Accordingly, a range of 6 months to 1 year, with a uniform distribution, was assumed for the length of time an infant breast-feeds. The upperbound value of 1 year was used in the deterministic assessment.
Estimating Intake via Mother's Milk Ingestion
'fhe equation for estimating the dose received by an infant is presented below. Uptake via ingestion of mother's milk is a function of the average chemical concen- 
where . . The values used to estimate the LADD via mother's milk ingestion are presented in Table 10 .-The 50th and 95th percentile LADDs are 1.8 X 10-15 and 1.6 X 10-14 mg/ kg-day (TEQ), respectively. The contribution of octa congeners to the dose via mother's milk was 50% and 52% at the 50th and 95th percentiles, respectively. The probability distribution for uptake via mother's milk is presented in Fig. 4 . The RME value predicted in the deterministic assessment was 3. 7 X I o-11 mg/kg-day, over three orders of magnitude greater than the 95th percentile dose.
RISK CHARACTERIZATION
Quantitative risk assessments are often limited by inadequate characterization of the uncertainty in the risk estimates. As recently discussed by USEPA, risk assessments ,.
... '· b:~sed on only a point estimate of risk "do not fully convey the range of information considered and used in developing the assessment" ( USEPA. 1991 b: Graham eta/., 1992 . The probabilistic approach to the characterization of health risk provides the risk manager with a more complete perspective on the potential variability in the risk estimate and can also identify factors contributing most significantly to variance in the risk results (Finkel. 1990: McKone and Bogen. 1991 ) . Furthermore. the characterization of risk as a probability distribution provides the risk manager with a tool for more appropriately evaluating (e.g., based on mathematical probability) the risk for the most highly exposed as well as the typical individual.
Carcinogenic Risk
The plausible incremental lifetime cancer risk (ILCR) was estimated as the product of lifetime average daily dose (LADD) (mg/kg-day) and cancer potency (mg/kg-day)-
•
Results of the Monte Carlo analysis are presented in Fig. 6 . Figure 6a presents the log 10 ILCR versus the relative probability for the final range of risks associated with residential exposure to PCDDs and PCDFs. Figure 6b presents the log 10 ILCR versus the cumulative probability for the predicted risk range. The cumulative probability is the sum of probabilities of all risk values less than and equal to the risk value being read. Presentation of risk as a cumulative function facilitates the interpretation of specific percentile risks. The results of the probabilistic assessment predicted a 95th percentile ICLR of 1.2 -X 10-7 • This value is considered a conservative estimate for a reasonable maximum exposure. The predicted risk at the 50th percentile. representative of the most likely exposure. was 1.8 X 10-8 • Comparatively, the risk calculated using the RME approach, based on the upperbound value for the revised CPF for 2,3.7,8-TCDD of 9700 (mg/ kg-dayf 1 and standard upperbound values for the exposure parameters. was 8.3 X 10- 6 . In this case, the predicted RME cancer risk exceeds the 95th percentile value predicted by the probabilistic assessment by approximately 70-fold.
One of the goals of this assessment was to understand the contribution of octa congeners to the total PCDD/PCDF risk. FIG. 6 . The probability distribution (a) and cumulative distribution (b) for incremental litetime cancer risk (ILCR) from exposure to PCCDs and PCDFs based on uncenainty in the cancer potency and key exposure factors. significantly to the total risk, with a 23% contribution at the 50th percentile risk and a 53% contribution at the 95th percentile risk. These contributions reflect the comparatively high soil and sediment concentrations of OCDD and OCDF, relative to other 2,3, 7 ,8-congeners detected.
As shown in Fig. 7 , the relative contribution of the pathway-specific risks to total risk is dependent on the subset of congeners assessed. When all congeners were considered, dermal contact represented 65% of the total at the 50th risk percentile and 84% of the total at the 95th risk percentile. Inhalation of particulates represented 17% of the risk at the 50th risk percentile and 6% of the risk at the 95th risk percentile. Ingestion of inhaled particulates represented 15 and 6% of the risk at 50th and 95th percentiles, respectively.
The variability of the relative contribution to risk is a consequence of the unique shapes of the individual input parameter distributions. This phenomenon needs to be recognized by risk managers when identifying those chemicals and exposure pathways which warrant the bulk of remediation and cost.
Comparison to Background Exposure
Background exposure to PCDD/PCDFs has been estimated to be approximately 0.03 to 2.86 pg/kg day based on mean human adipose tissue concentrations of 6 to 12 ppt (Kang eta/., 1991; Leung eta! .. 1990) . Travis and Hester ( 1990) have estimated the uptake due to ingestion of background levels of PCDDs and PCDFs in meat and dairy products to be 1.3 pg/kg-day (TEQ). This value falls within the ranges predicted by Kang et a/. (1991) and Leung eta/. ( 1990) . Using a cancer potency of 9700 (mgf kg-day)-1 , this background dose is associated with a plausible cancer risk of 1.26 X w-5 • These data indicate that the typical uptake of PCDD/PCDF associated with ingestion of food products is over two orders of magnitude greater than the highest plausible uptake of PCDD/PCDF, as predicted by the probabilistic assessment.
CONCLUSION
In summary, our assessment indicates the following:
• At least 95% of the persons potentially exposed to the PCDD/PCDF at this site do not have an incremental cancer risk greater than 1.2 X 10-7 • The most likely risk estimate, represented by the 50th percentile risk, should be no greater than 1.8 X I o-s.
• Octa congeners contributed significantly to the total ILCR. At the 50th and 95th percentiles, octa congeners represented 23 and 53% of the risk. respectively. In the deterministic assessment, octa congeners represented approximately 57% of the plausible cancer risk.
• The results of the deterministic assessment predicted a risk of 8.3 X 10-6 • This value is approximately 70-fold greater than the 95th percentile risk predicted in the probabilistic assessment and exceeds even the 99.9th percentile risk estimate.
• The 95th percentile risk for persons who live near the site is two orders of magnitude lower than the U.S. background cancer risk from the dietary intake of PCDD/PCDFs.
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